Filter
1823
Filtered Results: 1823
Text search:
Avert
Featured
Recommendations
132
New Publications
436
Language
Document type
No document type
874
Studies & Reports
354
Guidelines
274
Manuals
109
Strategic & Response Plan
100
Fact sheets
36
Training Material
27
Situation Updates
19
Infographics
16
Brochures
10
Online Courses
3
Resource Platforms
1
Countries / Regions
Global
111
Brazil
72
Kenya
50
Mozambique
48
Ethiopia
43
India
41
Africa
40
Nigeria
34
Latin America and the Carribbean
31
Senegal
29
Myanmar / Burma
26
Angola
25
South Africa
22
Zambia
22
Bangladesh
20
Uganda
20
Sierra Leone
19
Burkina Faso
19
Congo, Democratic Republic of
19
Guinea
18
Asia
18
Nepal
17
South–East Asia Region
16
Western and Central Europe
16
Paraguay
16
Tanzania
15
Liberia
14
Philippines
13
Guinea-Bissau
13
Venezuela
13
Ukraine
12
Rwanda
12
Syria
12
Malawi
12
Argentina
12
Mali
12
Cameroon
11
Peru
10
Namibia
10
South Sudan
10
Ghana
9
Cambodia
9
Germany
9
Yemen
9
Colombia
8
Benin
8
Chile
8
Haiti
8
Côte d’Ivoire / Ivory Coast
8
Lesotho
7
Ecuador
7
Pakistan
7
Zimbabwe
6
East and Southern Africa
6
Bolivia
6
Indonesia
6
Afghanistan
5
West and Central Africa
5
Portugal
5
Eastern Europe
5
Chad
5
Somalia
5
Niger
4
Tajikistan
3
Thailand
3
Togo
3
China
3
Kyrgyzstan
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
France
3
Lebanon
3
Vietnam
3
Russia
3
Sudan
3
Central African Republic
3
Honduras
3
Madagascar
3
Mexico
2
El Salvador
2
Kazakhstan
2
Estonia
2
Armenia
2
Western Pacific Region
2
Jamaica
2
Spain
2
Djibouti
2
Palestine
2
Botswana
2
Iraq
2
Eswatini/ Swaziland
2
Guatemala
2
North Macedonia
1
Serbia
1
Turkey
1
Gambia
1
Iran
1
Albania
1
Canada
1
Laos
1
Congo-Brazzaville
1
Burundi
1
Mauritania
1
Dominican Republic
1
Hungary
1
Luxembourg
1
Uruguay
1
Belgium
1
United Kingdom
1
Israel
1
Nicaragua
1
Moldova
1
Romania
1
Georgia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
682
Clinical Guidelines
125
Women & Child Health
111
Key Resources
91
Public Health
79
Pharmacy & Technologies
18
Capacity Building
13
Toolboxes
COVID-19
225
HIV
190
TB
108
Mental Health
87
Planetary Health
81
AMR
51
NTDs
48
Malaria
46
Conflict
43
Ebola & Marburg
39
Caregiver
39
Rapid Response
37
Health Financing Toolbox
33
Disability
32
Global Health Education
32
NCDs
24
Refugee
21
Natural Hazards
20
Pharmacy
17
Social Ethics
16
Zika
15
Specific Hazards
14
Polio
11
Cholera
9
2.0 Rapid Response
5
Typhoon
2
To meet our Strategy objectives and get within reach
of the 2030 SDG 3 target related to the three diseases,
the Global Fund needs to raise US$18 billion for the
Eighth Replenishment. That sum is essential to drive the
required pace of progress in the fight against HIV, TB
and malaria, and to m...
To deliver on the Global Fund Strategy milestones
for 2028 and ensure we keep the SDG 3 target
within reach, we need to raise US$18 billion to
fund the Global Fund’s next three-year grant cycle.
Development assistance for health (DAH)
plays a vital role in supporting health programmes in lowand middle-income countries. While DAH has historically
focused on infectious diseases and maternal and child
health, there is a lack of comprehensive analysis of DAH
trends, strategic shifts and the...
This publication uses graphics to explain the importance of development cooperation in general and for health in particular. Financial contributions in the context of development cooperation have proven to be indispensable, effective, affordable and responsible in recent decades.
2nd edition. This second edition builds on the experience of more than 10 years of SMC deployment, and reflects changes introduced in the WHO guidelines for malaria, 3 June 2022. The goal of this publication is to share these best practices to improve SMC implementation, coverage, and monitoring and...
The document outlines essential steps and provides guidance to countries on the adoption and deployment of c-IPTp so that it is integrated into the existing health system. It draws upon best practices and lessons learned from pilot implementation experiences in eight African countries and targets st...
This document by Medicines for Malaria Venture (MMV) highlights the significant burden of malaria on children worldwide, emphasizing the need for effective prevention, diagnosis, and treatment strategies. It reviews current challenges and progress in combating pediatric malaria, advocating for conti...
Report of a virtual meeting 21–23 June 2022
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...
Le pilier 3 de la Stratégie technique mondiale de lutte contre le paludisme 2016–2030 consiste à faire de la surveillance du paludisme une intervention de base dans tous les pays d’endémie palustre et dans ceux ayant éliminé le paludisme mais où la transmission pourrait reprendre. Ce nouve...
Preferred product characteristics and clinical development considerations
Depuis 2010, la lutte contre le paludisme a permis de réaliser des progrès majeurs grâce à la distribution de moustiquaires, au diagnostic rapide, aux traitements à base d'artémisinine (ACT) et aux interventions préventives ciblées.
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
This operational guidance provides a structured approach to support countries in sustaining priority services for HIV, viral hepatitis and sexually transmitted infections in the context of reduced external funding. The guidance is intended for national governments, public health programmes, communit...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
Noncommunicable diseases (NCDs) (e.g., cardiovascular diseases, cancers, diabetes, and chronic respiratory diseases) and mental health conditions (e.g., Alzheimer’s disease and related dementias, depression, anxiety, autism spectrum disorders) are the world’s leading cause of preventable illness...
